American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)

Objective:  The purpose of this study is to compare the incidences of bleeding and thrombosis, and the transfusion requirements in patients randomized to receive TXA or a placebo for hypoproliferative thrombocytopenia secondary to primary marrow disorders, chemotherapy, immunotherapy, radiation and/or hematopoietic stem cell transplant. NCT02578901.

2015-09-30 A-TREAT participation map.png




  • University of Washington 
    • Medical Center - Clinical Coordinating Center
    • Department of Biostatistics - Data Coordinating Center
  • University of Pittsburgh
  • University of North Carolina at Chapel Hill

If you have any queries regarding this protocol, or the general conduct of the trial, please contact